BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.680
+0.110 (7.01%)
Feb 10, 2026, 3:12 PM EST - Market open
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $36.74 million as of February 10, 2026. Its market cap has increased by 117.74% in one year.
Market Cap
36.74M
Enterprise Value
109.74M
1-Year Change
117.74%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $36.74M, a decrease of -78.71%. That is a compound annual growth rate of -17.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 34.34M | -1.88% |
| Dec 31, 2025 | 34.99M | 88.57% |
| Dec 31, 2024 | 18.56M | -78.51% |
| Dec 29, 2023 | 86.35M | -85.65% |
| Dec 30, 2022 | 601.94M | 5.82% |
| Dec 31, 2021 | 568.84M | -49.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Assertio Holdings | 81.75M |
| Cumberland Pharmaceuticals | 58.48M |
| InterCure | 49.55M |
| Rockwell Medical | 41.77M |
| Zhengye Biotechnology Holding | 39.83M |
| Talphera | 37.95M |
| SCYNEXIS | 31.85M |
| TherapeuticsMD | 26.51M |